Budesonide

Chemical formula: C₂₅H₃₄O₆  Molecular mass: 430.534 g/mol  PubChem compound: 5281004

Active ingredient description

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A07EA06 Budesonide A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EA Corticosteroids acting locally
Discover more medicines within A07EA06
D07AC09 Budesonide D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC09
R01AD05 Budesonide R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD05
R03BA02 Budesonide R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
PULMICORT TURBOHALER 100 Breath-actuated metered dose powder inhaler Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUDENOFALK Gastro-resistant capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUDESONIDE 64 Aqueous Nasal Spray Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUDENOFALK Rectal foam Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUDESONIDE Nebuliser Suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 51333-22-3
DrugBank Drug: DB01222
KEGG Drug: D00246
PubChem Compound: 5281004
RxNorm Ingredient: 19831
SNOMED-CT Concept: 395726003
Budesonide (substance)
UNII Identifier: Q3OKS62Q6X
BUDESONIDE

Medicines

Budesonide is an active ingredient of these brands:

United States (US)

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Ireland (IE)

Israel (IL)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.